Rxsight Inc
RXST7.862USD
+0.062+0.79%
Market hours （ET）Quotes delayed by 15 min
319.10MMarket Cap
LossP/E TTM
More Details of Rxsight Inc Company
RxSight, Inc. is a commercial-stage medical technology company, which is engaged in improving the vision of patients following cataract surgery. The Company’s RxSight Light Adjustable Lens system (RxSight system) is a cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system includes the RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and various accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. It designed its RxSight system to address the shortcomings of competitive IOL technologies and provide a solution that doctors can trust to improve visual outcomes. Its RxSight system helps the surgeon perform a standard cataract procedure to implant the LAL and then uses the LDD to modify the lens with the visual correction needed for the patient’s vision outcomes.
Company Info
Ticker SymbolRXST
Company nameRxsight Inc
IPO dateJul 30, 2021
CEODr. Ron M. Kurtz, M.D.
Number of employees498
Security typeOrdinary Share
Fiscal year-endJul 30
Address100 Columbia Street
CityALISO VIEJO
Stock exchangeNASDAQ Global Market Consolidated
CountryUnited States of America
Postal code92656
Phone19495217822
Websitehttps://www.rxsight.com/
Ticker SymbolRXST
IPO dateJul 30, 2021
CEODr. Ron M. Kurtz, M.D.
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
43.62K
--
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Dr. Ron M. Kurtz, M.D.
Dr. Ron M. Kurtz, M.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Juliet Tammenoms Bakker
Ms. Juliet Tammenoms Bakker
Independent Director
Independent Director
--
--
Mr. J. Andy Corley
Mr. J. Andy Corley
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Ms. Julie B. Andrews
Ms. Julie B. Andrews
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Eric Weinberg
Mr. Eric Weinberg
Co-President, Chief Commercial Officer
Co-President, Chief Commercial Officer
496.25K
+60.99%
Dr. William J. Link, Ph.D.
Dr. William J. Link, Ph.D.
Independent Director
Independent Director
59.10K
+22.24%
Dr. Ilya Goldshleger, Ph.D.
Dr. Ilya Goldshleger, Ph.D.
Co-President, Chief Operating Officer
Co-President, Chief Operating Officer
43.62K
--
Mr. Robert J. (Bob) Palmisano
Mr. Robert J. (Bob) Palmisano
Independent Director
Independent Director
41.04K
+35.50%
Ms. Shelley B. Thunen
Ms. Shelley B. Thunen
Co-President, Chief Financial Officer
Co-President, Chief Financial Officer
38.35K
-1.26%
Ms. Shweta Singh Maniar
Ms. Shweta Singh Maniar
Independent Director
Independent Director
18.14K
+145.63%
Revenue Breakdown
FY2024
No Data
By RegionUSD
Name
Revenue
Proportion
United States
139.93M
0.00%
By Business
By Region
No Data
Shareholding Stats
Updated: Mon, Jun 2
Updated: Mon, Jun 2
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
9.21%
Millennium Management LLC
6.43%
BlackRock Institutional Trust Company, N.A.
6.29%
Divisadero Street Capital Management, LP
6.23%
The Vanguard Group, Inc.
5.87%
Other
65.98%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
9.21%
Millennium Management LLC
6.43%
BlackRock Institutional Trust Company, N.A.
6.29%
Divisadero Street Capital Management, LP
6.23%
The Vanguard Group, Inc.
5.87%
Other
65.98%
Shareholder Types
Shareholders
Proportion
Investment Advisor
39.90%
Investment Advisor/Hedge Fund
20.21%
Hedge Fund
19.12%
Venture Capital
9.26%
Research Firm
7.81%
Individual Investor
5.51%
Pension Fund
1.27%
Private Equity
0.57%
Bank and Trust
0.46%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
444
40.56M
99.81%
-3.90M
2025Q1
453
40.49M
99.79%
-7.96M
2024Q4
440
38.96M
96.23%
-5.07M
2024Q3
420
38.15M
94.75%
-3.92M
2024Q2
391
37.00M
93.42%
-2.64M
2024Q1
338
34.63M
93.15%
-2.60M
2023Q4
299
33.17M
91.51%
-284.01K
2023Q3
253
34.41M
96.36%
-1.84M
2023Q2
214
31.39M
90.12%
+2.22M
2023Q1
160
26.47M
84.63%
+4.14M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
3.74M
9.21%
--
--
Mar 31, 2025
Millennium Management LLC
897.85K
2.21%
-109.69K
-10.89%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
2.56M
6.29%
-18.59K
-0.72%
Mar 31, 2025
Divisadero Street Capital Management, LP
2.53M
6.23%
+1.65M
+185.91%
Apr 03, 2025
The Vanguard Group, Inc.
2.38M
5.87%
+8.50K
+0.36%
Mar 31, 2025
BofA Global Research (US)
2.18M
5.37%
+35.62K
+1.66%
Mar 31, 2025
Artisan Partners Limited Partnership
1.77M
4.35%
+215.90K
+13.91%
Mar 31, 2025
Brown Capital Management, LLC
947.29K
2.33%
+105.10K
+12.48%
Mar 31, 2025
State Street Global Advisors (US)
898.67K
2.21%
+7.87K
+0.88%
Mar 31, 2025
Fidelity Management & Research Company LLC
888.74K
2.19%
-41.99K
-4.51%
Mar 31, 2025
View more
Related ETFs
Updated: Sat, Aug 2
Updated: Sat, Aug 2
Name
Proportion
SPDR S&P Health Care Equipment ETF
1.06%
iShares ESG Aware MSCI USA Small-Cap ETF
0.04%
Nuveen ESG Small-Cap ETF
0.04%
iShares Russell 2000 Growth ETF
0.03%
iShares Russell 2000 ETF
0.02%
WisdomTree US SmallCap Fund
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.02%
Global X Russell 2000 ETF
0.02%
Proshares Ultra Russell 2000
0.02%
View more
SPDR S&P Health Care Equipment ETF
Proportion1.06%
iShares ESG Aware MSCI USA Small-Cap ETF
Proportion0.04%
Nuveen ESG Small-Cap ETF
Proportion0.04%
iShares Russell 2000 Growth ETF
Proportion0.03%
iShares Russell 2000 ETF
Proportion0.02%
WisdomTree US SmallCap Fund
Proportion0.02%
ProShares Hedge Replication ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.02%
Proshares Ultra Russell 2000
Proportion0.02%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
